Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Mylan's peak revenue was $11.9B in 2017. The peak quarterly revenue was $3.3B in 2016(q4).
Mylan's revenue increased from $7.7b in 2014 to $11.5B currently. That's a 48.98% change in annual revenue.
| Fiscal year / year | Mylan revenue |
|---|---|
| 2014 | $7.7B |
| 2015 | $9.4B |
| 2016 | $11.1B |
| 2017 | $11.9B |
| 2018 | $11.4B |
| 2019 | $11.5B |
How accurately did Mylan's revenue projections match actual performance?
Mylan saw the greatest revenue growth in 2015, when revenue increased by 22.15%.
Mylan had the lowest revenue growth in 2018, when revenue changed by -3.98%.
| Year | Mylan growth |
|---|---|
| 2015 | 22%↑ |
| 2016 | 17%↑ |
| 2017 | 8%↑ |
| 2018 | -4%↓ |
| 2019 | 1%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2014 | - | - | - | $2.1B |
| 2015 | $1.9B | $2.4B | $2.7B | $2.5B |
| 2016 | $2.2B | $2.6B | $3.1B | $3.3B |
| 2017 | $2.7B | $3.0B | $3.0B | $3.2B |
| 2018 | $2.7B | $2.8B | $2.9B | $3.1B |
| 2019 | $2.5B | $2.9B | $3.0B | $3.2B |
| 2020 | $2.6B | $2.7B | $3.0B | - |
Do you work at Mylan?
Did Mylan meet its revenue projections?
| CEO | Heather Bresch |
| Company Type | Public |
| Employees Number | 35,000 |
| Date Founded | 1961 |
| Headquarters | Canonsburg, Pennsylvania |
| Number of Locations | 4 |
| Revenue | $11.5B |
| Net Income | $16,800,000 |
| Gross Proft | $3.9B (2019) |
| Tax Rate | 0.9% |
| Total Assets | $31,255,500,000 |
| Ticker | MYL |
Mylan's top competitor, Wyeth Biopharma, earned an annual revenue of $22.4B.
Mylan's smallest competitor is Watson Laboratories with revenue of $37.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| DPT Laboratories | $58,092 | $320.0M | 510 | - |
| Sun Pharmaceutical Industries Inc. | $72,061 | $4.2B | 32,000 | 146 |
| Watson Pharma Pvt Ltd | $79,372 | $5.9B | 21,600 | - |
| Pharmaceutics International | $67,963 | $367.8M | 1,000 | 9 |
| Par Pharmaceutical Inc | $61,975 | $260.0M | 400 | - |
| Tris Pharma | $67,691 | $102.0M | 200 | 14 |
| Sigma-Aldrich | $69,774 | $2.8B | 9,600 | - |
| Shire Pharmaceuticals Inc | $74,347 | $15.2B | 3,500 | - |
| Paddock Laboratories | $69,519 | $100.5M | 51 | - |
| Qualitest Pharmaceuticals | $44,685 | $230.0M | 7,500 | - |
Zippia gives an in-depth look into the details of Mylan, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Mylan. The employee data is based on information from people who have self-reported their past or current employments at Mylan. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Mylan. The data presented on this page does not represent the view of Mylan and its employees or that of Zippia.
Mylan may also be known as or be related to Mylan and Mylan Inc.